Crowdonomics
All companies
rHEALTH logo

rHEALTH

Operating

rHEALTH Inc.

Healthcare · Bedford, MA

Visit website

rHEALTH is a med-tech company developing a space-validated blood diagnostics platform for consumer and point-of-care use, with $23M in funding to date.

Post-money valuation ⓘ
$100.4M
As of Aug 2026 · from Reg CF Offering (2025) · pre-money + amount raised, not a traded price
Total raised
$497,267
Across 1 round since 2025

Financials

FY2023–FY2024 · from SEC filings · hover any figure for its source
$0
−$963K
2023
$800K
−$498K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023
FY2024
Income statement
Revenue
$0
$800,000
Cost of goods sold
$0
$0
Gross margin
—
100%
Net income
-$963,287
-$498,200
Taxes paid
$0
$0
Balance sheet
Cash
$29,270
$52,074
Accounts receivable
$0
$0
Total assets
$1,302,089
$1,028,506
Short-term debt
$325,705
$291,817
Long-term debt
$2,654,857
$2,835,400
Total liabilities
$2,980,562
$3,127,217
Other
Headcount
—
12

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$100.4M
post-money
Reg CF Offering (2025)

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Reg CF Offering (2025)ClosedReg CF · Convertible Note · via STARTENGINE PRIMARY LLC
Raised $497.3K / $1.2MInvestors 272Post-money $100.4M

Team

6 people
Eugene Y Chan, MDFounder
CEO, Principal Accounting Officer and Director

Physician-inventor honored by Esquire, MIT Technology Review and XPRIZE, with 60+ patents and work subject to > $200M+ in deals, exits; Harvard MD and summa cum laude Harvard graduate.

Eugene Y Chan
CEO, Principal Accounting Officer and Director
Dexter Eames
Hardware Engineer

MIT-trained engineer behind all rHEALTH hardware platforms, including the ISS-validated diagnostic units.

Jamie Cheng
Assay QC Manager

Leads assay QA and ISO 13485 compliance for IVD design; biochemistry graduate from Boston College.

Marcus Atkin
Industrial Designer

Designer of the rHEALTH device lineup with a background in medical product development and usability-focused engineering with experience at Philips, IDEO, and Dyson.

Samuel Bearg
Software Engineer

Instrumentation software engineer pivotal to XPRIZE wins and space-flown hardware; conducted advanced quantum dots research at UMass Amherst.

Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 1 annual reports (FY2025)

Missing: 2025

272 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UAug 31, 20260002100356-26-000008
    EDGAR
  • Form C/AJun 17, 20260002100356-26-000007
    EDGAR
  • Form C/AApr 23, 20260002100356-26-000005
    EDGAR
  • Form C/AFeb 17, 20260002100356-26-000002
    EDGAR
  • Form CDec 18, 20250002100356-25-000002
    EDGAR
Source: SEC EDGARCIK 0002100356DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.